VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $571,000 | -77.4% | 18,700 | -84.8% | 0.02% | -78.6% |
| Q1 2018 | $2,522,000 | -23.1% | 123,000 | -2.0% | 0.10% | -25.8% |
| Q4 2017 | $3,278,000 | +17.7% | 125,500 | -19.6% | 0.13% | +9.1% |
| Q3 2017 | $2,786,000 | -20.4% | 156,100 | 0.0% | 0.12% | -21.9% |
| Q2 2017 | $3,501,000 | +57.9% | 156,100 | +3.2% | 0.16% | +72.2% |
| Q1 2017 | $2,217,000 | -30.4% | 151,200 | -7.6% | 0.09% | -23.7% |
| Q4 2016 | $3,185,000 | -40.4% | 163,600 | -1.4% | 0.12% | -41.6% |
| Q3 2016 | $5,342,000 | +20.4% | 166,000 | -2.8% | 0.20% | +12.2% |
| Q2 2016 | $4,436,000 | -46.3% | 170,800 | -29.7% | 0.18% | -46.7% |
| Q1 2016 | $8,261,000 | -69.4% | 242,910 | +26.5% | 0.34% | -71.9% |
| Q4 2015 | $26,970,000 | -33.7% | 192,000 | +12.3% | 1.20% | -33.8% |
| Q3 2015 | $40,698,000 | -9.5% | 171,020 | +5.3% | 1.82% | -2.1% |
| Q2 2015 | $44,982,000 | +19.2% | 162,400 | +7.6% | 1.85% | +21.8% |
| Q1 2015 | $37,725,000 | +28.7% | 150,880 | -14.6% | 1.52% | +30.5% |
| Q4 2014 | $29,306,000 | +2.2% | 176,600 | -10.0% | 1.17% | -1.0% |
| Q3 2014 | $28,683,000 | +7.3% | 196,190 | -1.5% | 1.18% | +8.1% |
| Q2 2014 | $26,726,000 | +1.2% | 199,080 | +9.4% | 1.09% | -6.3% |
| Q1 2014 | $26,413,000 | +25.8% | 182,010 | +8.1% | 1.16% | +14.8% |
| Q4 2013 | $20,990,000 | +11.4% | 168,430 | -4.2% | 1.01% | +2.0% |
| Q3 2013 | $18,839,000 | -31.0% | 175,730 | -41.8% | 0.99% | -30.8% |
| Q2 2013 | $27,303,000 | – | 302,020 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |